Parkinson's Disease Trial, Recruiting (NCT05065151)

Parkinson's Disease Trial, Recruiting NCT05065151 Sponsor: University of California, San Francisco Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05065151 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Parkinson's Disease or Dystonia
People who have a specific Medtronic brand brain stimulation device (either the Percept or RC+S model) already implanted in one of two specific brain regions (either the GPI or STN)
People whose brain stimulation device was implanted on one side or both sides of the brain
People of any gender
People who had their brain stimulation device implanted more than 1 month ago

Who may not be able to join:

People who have severe difficulties with thinking, memory, or understanding
People whose score on a standard memory and thinking test (called the MoCA) is below 20 out of 30
People who are currently pregnant
People who are under 18 years of age

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Simon J Little, MBBS, PhD, University of California, San Francisco

Phone: 415-353-7885

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05065151

Sponsor: University of California, San Francisco

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 415-353-7885

More information: https://clinicaltrials.gov/study/NCT05065151

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Parkinson's Disease or Dystonia
People who have a specific Medtronic brand brain stimulation device (either the Percept or RC+S model) already implanted in one of two specific brain regions (either the GPI or STN)
People whose brain stimulation device was implanted on one side or both sides of the brain
People of any gender
People who had their brain stimulation device implanted more than 1 month ago

Who may not be able to join:

People who have severe difficulties with thinking, memory, or understanding
People whose score on a standard memory and thinking test (called the MoCA) is below 20 out of 30
People who are currently pregnant
People who are under 18 years of age

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

30 October 2021

Est. completion

1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent of Risky Decisions made with Percept DBS stimulation on for Parkinson's Disease Patients; Percent of Risky Decisions made with Percept DBS stimulation off for Parkinson's Disease Patients; Reaction Time During Decision-Making Task; Task Success Rate; Acceptance Rate of Risky Versus Safe Options; Force Exertion During Motor Responses; Low frequency local field potentials; Electroencephalogram (EEG) theta band power; Electroencephalogram (EEG) beta band power; Electroencephalogram (EEG) gamma band power; Electroencephalogram (EEG) alpha band power

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov